Modulation of redox homeostasis: A strategy to overcome cancer drug resistance
Frontiers in Pharmacology · 22.03.2023 · 14
DOI: 10.3389/fphar.2023.1156538 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 22.03.2023. Verfasst von Yang Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Biotherapy and Cancer Center, West China School of Basic Medical Sciences and Forensic Medicine, West China Hospital, and Col…. Die Arbeit wurde bisher 78-mal zitiert (Crossref) und nennt 196 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cancer treatment is hampered by resistance to conventional therapeutic strategies, including chemotherapy, immunotherapy, and targeted therapy. Redox homeostasis manipulation is one of the most effective innovative treatment techniques for overcoming drug resistance. Reactive oxygen species (ROS), previously considered intracellular byproducts of aerobic metabolism, are now known to regulate multiple signaling pathways as second messengers. Cancer cells cope with elevated amounts of ROS during therapy by upregulating the antioxidant system, enabling tumor therapeutic resistance via a variety of mechanisms. In this review, we aim to shed light on redox modification and signaling pathways that may contribute to therapeutic resistance. We summarized the molecular mechanisms by which redox signaling-regulated drug resistance, including altered drug efflux, action targets and metabolism, enhanced DNA damage repair, maintained stemness, and reshaped tumor microenvironment. A comprehensive understanding of these interrelationships should improve treatment efficacy from a fundamental and clinical research point of view.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Biotherapy and Cancer Center, West China School of Basic Medical Sciences and Forensic Medicine, West China Hospital, and Collaborative Innovation Center for Biotherapy, Sichuan University, Cheng…
- Key Laboratory of Birth Defects and Related Diseases of Women and Children of Ministry of Education, Department of Reproductive Medicine, West China Second University Hospital of Sichuan University, Chengdu, China.
Zitieren
APA
Li, Y., Zhang, X., Wang, Z., Li, B., & Zhu, H. (2023). Modulation of redox homeostasis: A strategy to overcome cancer drug resistance. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1156538
Vancouver
Li Y, Zhang X, Wang Z, Li B, Zhu H. Modulation of redox homeostasis: A strategy to overcome cancer drug resistance. Frontiers in Pharmacology. 2023;14. doi:10.3389/fphar.2023.1156538
BibTeX
@article{Li2023,
author = {Li, Yang and Zhang, Xiaoyue and Wang, Zhihan and Li, Bowen and Zhu, Huili},
title = {Modulation of redox homeostasis: A strategy to overcome cancer drug resistance},
journal = {Frontiers in Pharmacology},
year = {2023},
volume = {14},
doi = {10.3389/fphar.2023.1156538}
}
EUVIMED